A novel mutation in the NOD2 gene associated with Blau syndrome a Norwegian family with four affected members

Scandinavian Journal of Rheumatology

Volumn 38, Issue 3, 2009, Pages 190-197

  Milman, N ^a,c   Ursin, K ^b   Rodevand E ^b   Nielsen, F C ^a   Hansen, T V O ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; NOD2 PROTEIN, HUMAN;

AGED; ARTHRITIS; ARTICLE; BLAU SYNDROME; CHILD; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GRANULOMATOUS INFLAMMATION; HETEROZYGOSITY; HUMAN; LYMPHADENITIS; MALE; PAROTITIS; PRIORITY JOURNAL; RASH; UVEITIS; ADOLESCENT; ADULT; CASE REPORT; DERMATITIS; FAMILY HEALTH; GENETICS; GRANULOMA; NORWAY; PEDIGREE; POINT MUTATION; SKIN DISEASE; SYNDROME;

ADOLESCENT; ADULT; AGED; ARTHRITIS; DERMATITIS; FAMILY HEALTH; FEMALE; GRANULOMA; HUMANS; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; NORWAY; PEDIGREE; POINT MUTATION; SKIN DISEASES, GENETIC; SYNDROME; UVEITIS;

EID: 65649103757     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802464194     Document Type: Article

References (32)

1. Blau EB. Familial granulomatous arthritis, iritis and rash. J Pediatr 1985;107:689-693
2. Pastores GM, Michels VV, Stickler GB, Su WP, Nelson AM, Bovenmyer DA. Autosomal dominant granulomatous arthritis, uveitis, skin rash and synovial cysts. J Pediatr 1990;117: 403-408
3. Manouvrier-Hanu S, Puech B, Piette F, Boute-Benejean O, Desbonnet A, Duquesnoy B, et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: A new family and review of the literature. Am J Med Gen 1998 217-222
4. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Häfner R, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20.
5. Wang X, Kuivaniemi H, Bonavita G, Mutkus L, Mau U, Blau E, et al. CARD15 mutations in familial granulomatosis syndrome. Arthritis Rheum 2002;30:41-45
6. Priori R, Bombardieri M, Spinelli FR, Merlin F, Miceli- Richard C, La Cava M, et al. Sporadic Blau syndrome with a double CARD15 mutation. Report of a case with a lifelong follow-up. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:228-231
7. Rosé CD, Doyle TM, McIlvain-Simpson G, Coffman JE, Rosenbaum JT, Davey MP, et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 2005;32:373-375
8. Rosé CD, Wouters CH, Meiorin S, Doyle TM, Davey MP, Rosenbaum JT, et al. Pediatric granulomatous arthritis: An international registry. Arthritis Rheum 2006;54:3337-3344
9. Aró stegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin- 1 blockade in a Spanish cohort. Arthritis Rheum 2007;56:3805-3813
10. Milman N, Andersen CB, Hansen A, van Overeem Hansen T, Nielsen FC, Fledelius H, et al. Favourable effect of TNFa inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 2006;114: 212-219
11. Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata- Hizume M, Nagai S, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 2005;105:1195-1197
12. van Duist MM, Albrecht M, Podswiadek M, Giachino D, Lengauer T, Punzi L, et al. A new Card15 mutation in Blau syndrome. Eur J Hum Genet 2005;13:742-747
13. Becker ML, Rosé CD. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep 2005;7:427-433
14. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-857
15. Schurmann M, Valentonyte R, Hampe J, Müller-Quernheim J, Schwinger E, Schreiber S, et al. CARD15 gene mutations in sarcoidosis. Eur J Resp Dis 2003;22:748-754
16. MilmanN,NielsenFC, HviidTVF,HansenTvO.Blau syndromeassociated mutations in exon 4 of the caspase activating recruitment domain 15 (CARD15) gene are not found in ethnic Danes with sarcoidosis. Clin Respir J 2007;1:74-79
17. Andersen PS, Jespersgaard C, Vuust J, Christiansen M. High-throughput single strand conformation polymorphism mutation detection by automated capillary array electrophoresis: validation of the method. Hum Mutat 2003;21: 116-122
18. Rybicki BA, Maliarik MJ, Bock CH, Elston RC, Baughman RP, Kimani AP, et al. The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:203-208
19. Masel G, Halbert A. Blau syndrome presenting with ichthyosis. Australas J Dermatol 2005;46:29-32.
20. Hoffmann L, Milman N, Byg K-E. Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical features and laboratory results in 48 children. Acta Pædiatr 2004;93:30-36
21. Ting SS, Ziegler J, Fischer E. Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr 1998;133:450-452
22. Becker ML, Martin TM, Doyle TM, Rosé CD. Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis Rheum 2007;56:1292-1294
23. North AE, Fink CW, Gibson WM, Levinson JE, Schuchter SL, Howard WK, et al. Sarcoid arthritis in children. Am J Med 1970;48:449-455
24. Hetherington S. Sarcoidosis in young children. Am J Dis Child 1982;136:13-15.
25. Pattishall EN, Kendig EL. Sarcoidosis in children. Pediatr Pulmonol 1996;22:195-203.
26. King K, Sheikh MF, Cuthbert AP, Fisher SA, Onnie CM, MirzaMM, et al.Mutation, selection, and evolution of theCrohn disease susceptibility geneCARD15. HumMutat 2006;27:44-54.
27. Carneiro LAM, Travassos LH, Girardin SE. Nod-like receptors in innate immunity and inflammatory diseases. Ann Med 2007;39:581-593
28. Chamaillard M, Philpott S, Girardin SF, Zouali H, Lesage S, Chareyre F, et al. Gene-environment interaction moduled by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003;100:3455-3460
29. Moller DR. Treatment of sarcoidosis - from a basic science point of view. J Intern Med 2003;253:31-40.
30. Fehrenbach H, Zissel G, Goldmann T, Tschernig T, Vollmer E, Pabst R, et al. Alveolar macrophages are the main source for tumour necrosis factor-a in patients with sarcoidosis. Eur Resp J 2003;21:421-428
31. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005;127:1064-1071
32. Wyser CP, van Schlakwyk EM, Alheit B, Bardin PG, Joubert JR, et al. Treatment of progressive pulmonary sarcoidosis with cyclosporin A: A randomized controlled trial. Am J Respir Crit Care Med 1997;156:1571-1576